[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)
Status:
RECRUITING
Trial end date:
2027-06-01
Target enrollment:
Participant gender:
Summary
This is a prospective study using \[68Ga\]Ga DOTA-5G PET/CT imaging in patients diagnosed with metastatic/advanced invasive lobular breast cancer (LBC).
Phase:
PHASE1
Details
Lead Sponsor:
University of California, Davis
Collaborators:
Dr. Cameron Foster, University of California Davis Dr. Helen K Chew, University of California Davis Society of Nuclear Medicine and Molecular Imaging